Trials / Completed
CompletedNCT01293734
Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 360 (actual)
- Sponsor
- Liaoning University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Bronchial asthma is a common disease and frequently encountered disease of respiratory apparatus. It has very complex mechanism and multiple inducing factors. This study will focus on a new Chinese therapy on Bronchial asthma, analyzing the treatment mechanism of internal and external use, based on Traditional Chinese Medicine (TCM) theory and clinical practice. The study will also investigate the efficacy of the Chinese drugs and treatments on Bronchial asthma, and provide an effective therapy for this disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | warming lung and relieving asthmatic granule and Securing origin and warming lung emplastrum | warming lung and relieving asthmatic granule:once 1 bag, 3 times a day. Securing origin and warming lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day |
| OTHER | clearing lung and relieving asthmatic granule and securing origin and clearing lung emplastrum | clearing lung and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and clearing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day |
| OTHER | securing origin and relieving asthmatic granule and securing origin and nourishing lung emplastrum | securing origin and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and nourishing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day |
| DRUG | Theophylline Sustained-release Tablets and budesonide suspension | Theophylline Sustained-release Tablets 0.2g a time, twice a day. budesonide suspension for inhalation 100ug, twice a day |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2011-01-01
- Completion
- 2011-02-01
- First posted
- 2011-02-11
- Last updated
- 2011-02-11
Source: ClinicalTrials.gov record NCT01293734. Inclusion in this directory is not an endorsement.